Trade Summary

3 days ago, Pham Quang X, serving as Chairman, CEO and Interim CFO at Cadrenal Therapeutics, Inc. (CVKD), sold 22,385 shares at $4.17 per share, for a total transaction value of $93,293.86. Following this transaction, Pham Quang X now holds 150,839 shares of CVKD.

This sale represents a 12.92% decrease in Pham Quang X's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 8, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 (accepted Jun 10, 8:26 PM ET), 3 days after the trade was made.

Cadrenal Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.